Source comparison
Comparison: Key GHRH Analogs for Research
To further contextualize the CJC-1295 history, let's look at how its different forms and related compounds compare. This helps illustrate why specific choices are made in research settings. Mechanism GHRH analog, binds to albumin GHRH analog GHRP (ghrelin rece
This comparison does not assign a generated winner or score.
- To further contextualize the CJC-1295 history, let's look at how its different forms and related compounds compare. This helps illustrate why specific choices are made in research settings.
- Mechanism
- GHRH analog, binds to albumin
- GHRH analog
- GHRP (ghrelin receptor agonist)
- Half-Life
- ~6-8 days
- ~30 minutes
- ~2 hours
- ~10-20 minutes
- GH Release
- Sustained, elevated GH/IGF-1
- Pulsatile, natural GH pulses
- Pulsatile, strong GH bursts
- Primary Use
- Long-term, consistent GH release
- Mimics natural GH rhythm
- Synergistic with GHRH analogs
- Short-acting GH release
- Synergy
- Often combined with GHRPs
- Often combined with GHRH analogs
- Historical Role
- Groundbreaking long-acting GHRH
- Focus on natural pulsatility
- Selective GHRP, strong safety data
- Early GHRH mimetic, foundational
- This table highlights the distinct advantages of each compound within the broader field of Growth Hormone Secretagogues (GHS). The choice often depends on the specific kinetics and physiological effects a researcher is aiming to achieve. For instance, while CJC-1295 (no DAC) offers a more natural pulsatile release, the extended action of CJC-1295 (with DAC) (or a blend like CJC-1295 + Ipamorelin (5mg/5mg)) can be invaluable for studies requiring consistent, sustained elevation over longer periods.